Cargando…
Sieve analysis to understand how SARS-CoV-2 diversity can impact vaccine protection
Autores principales: | Rolland, Morgane, Gilbert, Peter B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993616/ https://www.ncbi.nlm.nih.gov/pubmed/33765086 http://dx.doi.org/10.1371/journal.ppat.1009406 |
Ejemplares similares
-
Current status of therapeutic monoclonal antibodies against SARS-CoV-2
por: Kumar, Sanjeev, et al.
Publicado: (2021) -
Airway models in a pandemic: Suitability of models in modeling SARS-CoV-2
por: Teo, Andrew, et al.
Publicado: (2022) -
Harnessing early life immunity to develop a pediatric HIV vaccine that can protect through adolescence
por: Goswami, Ria, et al.
Publicado: (2020) -
Ash dieback epidemic in Europe: How can molecular technologies help?
por: Downie, J. Allan
Publicado: (2017) -
Lessons from Nature: Understanding Immunity to HCV to Guide Vaccine Design
por: Freeman, Zachary T., et al.
Publicado: (2016)